(Q51961251)

19 April 2018

title

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. (English)

1 reference

19 April 2018

1 reference

0 references

2

1 reference

19 April 2018

Marc Steben

20

1 reference

19 April 2018

Christine C Roberts

29

1 reference

19 April 2018

Joakim Dillner

22

Joakim Dillner

1 reference

19 April 2018

3

Cosette M Wheeler

1 reference

19 April 2018

Jorma Paavonen

18

Jorma Paavonen

1 reference

19 April 2018

Sławomir Majewski

24

Slawomir Majewski

1 reference

19 April 2018

Nubia Muñoz

25

Nubia Muñoz

1 reference

19 April 2018

Laura Koutsky

9

Laura A Koutsky

1 reference

19 April 2018

Suzanne Marie Garland

13

Suzanne M Garland

1 reference

19 April 2018

author name string

Elmar A Joura

1

1 reference

19 April 2018

Kristján Sigurdsson

4

1 reference

19 April 2018

Ole-Erik Iversen

5

1 reference

19 April 2018

Mauricio Hernandez-Avila

6

1 reference

19 April 2018

Gonzalo Perez

7

1 reference

19 April 2018

Darron R Brown

8

1 reference

19 April 2018

Eng Hseon Tay

10

1 reference

19 April 2018

Patricia García

11

1 reference

19 April 2018

Kevin A Ault

12

1 reference

19 April 2018

Sepp Leodolter

14

1 reference

19 April 2018

Sven-Eric Olsson

15

1 reference

19 April 2018

Grace W K Tang

16

1 reference

19 April 2018

Daron G Ferris

17

1 reference

19 April 2018

Matti Lehtinen

19

1 reference

19 April 2018

Xavier Bosch

21

1 reference

19 April 2018

Robert J Kurman

23

1 reference

19 April 2018

Evan R Myers

26

1 reference

19 April 2018

Luisa L Villa

27

1 reference

19 April 2018

Frank J Taddeo

28

1 reference

19 April 2018

Amha Tadesse

30

1 reference

19 April 2018

Janine Bryan

31

1 reference

19 April 2018

Lisa C Lupinacci

32

1 reference

19 April 2018

Katherine E D Giacoletti

33

1 reference

19 April 2018

Shuang Lu

34

1 reference

19 April 2018

Scott Vuocolo

35

1 reference

19 April 2018

Teresa M Hesley

36

1 reference

19 April 2018

Richard M Haupt

37

1 reference

19 April 2018

Eliav Barr

38

1 reference

19 April 2018

language of work or name

English

0 references

publication date

16 October 2008

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

26

1 reference

19 April 2018

issue

52

1 reference

19 April 2018

page(s)

6844-6851

1 reference

19 April 2018

Epidemiology of Genital Human Papillomavirus Infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

The role of human papillomaviruses in anogenital cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

A population-based study of squamous cell vaginal cancer: HPV and cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Clinical implications of human papillomavirus in head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Latent papillomavirus and recurring genital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

The 2001 Bethesda System: terminology for reporting results of cervical cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.073

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.09.073

1 reference

19 April 2018

PubMed ID

18930097

1 reference

19 April 2018